Compare · head to head
Dong-A Socio vs JW Pharmaceutical
JW Pharmaceutical ranks higher overall — 360 rank 95 vs 85.
JW Pharmaceutical leads on Safety (61 vs 33). Dong-A Socio leads on Sentiment (60 vs 45). The two are close on Value, Quality and Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7000640003 | KR7001060003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 85 | 95 |
| Value | 65 | 69 |
| Quality | 74 | 74 |
| Growth | 56 | 56 |
| Safety | 33 | 61 |
| Sentiment | 60 | 45 |
| Quality details | ||
| Profitability | 69 | 92 |
| Cash Truth | 80 | 55 |
Dong-A Socio vs Kwangdong PharmaceuticalDong-A Socio vs Hanmi PharmaceuticalDong-A Socio vs Aprogen BiologicsDong-A Socio vs Sumitomo Dainippon PharmaAdd a third stock →
Full analyses: Dong-A Socio · JW Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100